Prosecution Insights
Last updated: November 20, 2026

Daniel Lee Cerioni, USPTO Patent Examiner

Listed by the USPTO as CERIONI, DANIEL LEE

Tech Center 3700 • Art Units: 3736 3791 3792

This examiner grants 64% of resolved cases

Analysis

CERIONI, DANIEL LEE has resolved 793 cases in tech center 3700 and art unit 3736. The allowance rate is 64.4%, with an interview lift of 27.6%. The median time to allowance is 1291 days. The substantial case volume makes the allowance and interview figures useful indicators of recurring prosecution conditions rather than isolated results.

The leading companies are Abbott Laboratories, ViOptix Inc., and GE Precision Healthcare LLC. The leading firms are AMPACC Law Group PLLC, BUCHANAN INGERSOLL & ROONEY PC, and Dentons Durham Jones Pinegar. Interviews appear to be a meaningful part of the prosecution process, but the median timing shows that obtaining allowance may require extended case management. Practitioners should prepare interview objectives that connect directly to claim amendments and evidence in the record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

64.4%
Allow Rate
-5.6% vs TC avg
885
Total Applications
+27.6%
Interview Lift
1291
Avg Prosecution Days
Based on 793 resolved cases, 2023–2026

Rejection Statute Breakdown

10.0%
§101 Eligibility
12.7%
§102 Novelty
42.9%
§103 Obviousness
32.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19231341 MOTION ACTIVITY BASED ESCALATION OF HEART RATE SENSOR Non-Final OA Apple Inc.
18973934 BIOPSY CAP ASSEMBLIES Non-Final OA Boston Scientific Medical Device Limited
18782190 OXYGEN MEASUREMENT DEVICE AND OXYGEN MEASUREMENT SYSTEM Non-Final OA TERUMO KABUSHIKI KAISHA
18173753 SENSING SYSTEMS AND METHODS FOR PROVIDING DECISION SUPPORT AROUND KIDNEY HEALTH AND/OR DIABETES Final Rejection Dexcom, Inc.
18938592 NEONATAL POD WITH CHARGER Final Rejection GE Precision Healthcare LLC
18647171 METHOD FOR ESTIMATING A BODY SURFACE AREA OF A SUBJECT AND MEDICAL IMAGING DEVICE Non-Final OA Siemens Healthineers AG
18710896 Implant Arrangement Enabling Virtual Programming of an Implant Final Rejection BIOTRONIK SE & Co. KG
18789387 BACKGROUND INTERFERENCE MITIGATION FOR HIGH SENSITIVITY CREATININE SENSING Final Rejection ABBOTT DIABETES CARE INC.
18321265 MEDICAL DEVICE INCLUDING A SOLDERABLE LINEAR ELASTIC NICKEL-TITANIUM DISTAL END SECTION AND METHODS OF PREPARATION THEREFOR Non-Final OA Abbott Cardiovascular Systems, Inc.
17723365 CATHETER WITH ATRAUMATIC TIP Final Rejection St. Jude Medical, Atrial Fibrillation Division Inc
17416431 METHOD FOR EVALUATING USAGE DATA Final Rejection Otto Bock Healthcare Products GmbH
19040904 METHOD AND SYSTEM FOR SIGNAL ELEVATION BASED MUSCLE ACTIVITY DETECTION Non-Final OA Tata Consultancy Services Limited
19227121 BRAIN WAVE PATTERN CHARACTERIZATION Non-Final OA The Texas A&M University System
18611917 SENSOR WITH VARYING STIFFNESS Non-Final OA Roche Diabetes Care, Inc.
15920966 Catheter Assembly With Offset Device For Tissue Sampling Non-Final OA GYRUS ACMI, INC D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
17151081 FLEXIBLE SURGICAL INSTRUMENTS FOR PERCUTANEOUS AND NEUROSURGICAL APPLICATIONS Non-Final OA The Chinese University of Hong Kong
18669801 IMPLANTABLE CHEMICAL SENSOR PACKAGES WITH CALIBRATION FEATURES Final Rejection Cardiac Pacemakers, Inc.
18135837 Blood Saving Blood Collection Device Non-Final OA Becton, Dickinson and Company
18117765 Blood Access Device with Integrated Blood Diagnostics Final Rejection Becton, Dickinson and Company
17995865 APPARATUS AND METHODS FOR ACQUISITION OF MICROBIOPSY TISSUE SAMPLES USING A LASER Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18965670 SENSING PLATFORMS WITH NEEDLES AND METHODS OF FABRICATION AND USE Non-Final OA Purdue Research Foundation
17970095 POINT-OF-CARE ASSESSMENT SYSTEM Final Rejection The Curators of the University of Missouri
18833605 EVALUATION METHOD, EVALUATION APPARATUS, AND RECORDING MEDIUM Final Rejection SHISEIDO COMPANY, LTD.
18979814 Methods And Kits For Assessing Central Nervous System Integrity Non-Final OA THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Daniel Lee Cerioni's allowance rate?

64.4% of resolved applications examined by Daniel Lee Cerioni were allowed (793 resolved cases), compared with 56.2% across Art Unit 3736 over the last five years.

Does an interview help with examiner Daniel Lee Cerioni?

This examiner's interview lift is +27.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Daniel Lee Cerioni take to allow a patent?

Applications allowed by Daniel Lee Cerioni took 1,291 days on average from filing to allowance.

Which art unit does examiner Daniel Lee Cerioni work in?

Daniel Lee Cerioni examines applications in Art Unit 3736 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month